Nexus Finance
SRT3.DE SARTORIUS AG V | DE0007165631

Company Profile

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Latest News

Sector Healthcare
Industry Medical Instruments & Supplies
Website https://www.sartorius.com
Audit Risk 2
Board Risk 6
Overall Risk 8
Market Cap 15.15B
Trailing P/E 77.53
Forward P/E 34.75
Dividend Rate 0.74
Dividend Yield 0.33%
Trailing Annual Div. Rate 0.74
Trailing Annual Div. Yield 0.33%
Trailing EPS 2.83
Forward EPS 6.31
Book Value 39.2
Price-to-Book 5.6
Enterprise-to-Revenue 5.64
Enterprise-to-EBITDA 21.52
Ex-Dividend Date 03/27/2026
Earnings Date
Earnings Call Date
Earnings Average 1.23
Earnings Low 1.13
Earnings High 1.29
Revenue Average 897.82M
Revenue Low 890.00M
Revenue High 909.08M
ende